1. Home
  2. SSTK vs CERS Comparison

SSTK vs CERS Comparison

Compare SSTK & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shutterstock Inc.

SSTK

Shutterstock Inc.

HOLD

Current Price

$4.55

Market Cap

570.9M

Sector

Technology

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.59

Market Cap

534.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSTK
CERS
Founded
2003
1991
Country
United States
United States
Employees
N/A
345
Industry
EDP Services
EDP Services
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
570.9M
534.0M
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
SSTK
CERS
Price
$4.55
$2.59
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
880.8K
1.3M
Earning Date
04-28-2026
04-30-2026
Dividend Yield
8.61%
N/A
EPS Growth
23.76
27.27
EPS
N/A
N/A
Revenue
N/A
$51,326,000.00
Revenue This Year
$4.35
$19.95
Revenue Next Year
N/A
$8.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.68
52 Week Low
$4.41
$1.38
52 Week High
$29.50
$3.47

Technical Indicators

Market Signals
Indicator
SSTK
CERS
Relative Strength Index (RSI) 32.90 N/A
Support Level N/A N/A
Resistance Level $6.10 N/A
Average True Range (ATR) 0.28 0.00
MACD -0.01 0.00
Stochastic Oscillator 11.24 0.00

Price Performance

Historical Comparison
SSTK
CERS

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

Share on Social Networks: